Specifically, in TCGA-KIRC cohort, we observed that TUBA1C expression markedly influenced the outcomes of ccRCC patients, including OS, PFS, and DPI (Figure 4E). This evidence concerns the gene TUBA1C and nonpapillary renal cell carcinoma.